Reduction of the in vitro pro-inflammatory response by macrophages to poly(3-hydroxybutyrate-co-3-hydroxyvalerate)

Biomaterials

Volumn 27, Issue 27, 2006, Pages 4715-4725

  Wu, Andy C K ^a   Grøndahl, Lisbeth ^a   Jack, Kevin S ^a   Foo, Michelle X ^a   Trau, Matt ^a   Hume, David A ^a   Cassady, Alan I ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Biocompatibility; Endotoxin; Inflammation; Macrophage

Indexed keywords

BACTERIA; BIOCOMPATIBILITY; BIOPOLYMERS; CELLS; HYDROGEN PEROXIDE; MICROORGANISMS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PLASTIC FILMS; POLYESTERS; POLYSACCHARIDES; THERMOPLASTICS;

ENDOTOXIN; INFLAMMATION; MACROPHAGE; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE) (PHBV);

METABOLISM;

BACTERIAL DNA; BIOMATERIAL; BIOPOLYMER; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; POLY(3 HYDROXYBUTYRATE CO 3 HYDROXYVALERATE); TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CHEMICAL STRUCTURE; CONTROLLED STUDY; CPG ISLAND; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POLYESTERS;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 33744945508     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.05.010     Document Type: Article

References (41)

1. Williams K.R., and Blayney A.W. Tissue response of several polymeric materials implanted in the rat middle ear. Biomaterials 8 4 (1987) 254-258
2. Hume D.A., Ross I.L., Himes S.R., Sasmono R.T., Wells C.A., and Ravasi T. The mononuclear phagocyte system revisited. J Leukoc Biol 72 4 (2002) 621-627
3. Hume D.A., Underhill D.M., Sweet M.J., Ozinsky A.O., Liew F.Y., and Aderem A. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol 2 (2001) 11
4. Tang L., and Eaton J.W. Inflammatory responses to biomaterials. Am J Clin Pathol 103 4 (1995) 466-471
5. Betz R.R. Limitations of autograft and allograft: new synthetic solutions. Orthopedics 25 Suppl. 5 (2002) S561-S570
6. Nitschke M., Schmack G., Janke A., Simon F., Pleul D., and Werner C. Low pressure plasma treatment of poly(3-hydroxybutyrate): toward tailored polymer surfaces for tissue engineering scaffolds. J Biomed Mater Res 59 4 (2002) 632-638
7. Köse G.T., Korkusuz F., Korkusuz P., Purali N., Ozkul A., and Hasirci V. Bone generation on PHBV matrices: an in vitro study. Biomaterials 24 27 (2003) 4999-5007
8. Hankermeyer C.R., and Tjeerdema R.S. Polyhydroxybutyrate: plastic made and degraded by microorganisms. Rev Environ Contam Toxicol 159 (1999) 1-24
9. Li H., Du R., and Chang J. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass. J Biomater Appl 20 2 (2005) 137-155
10. Li H., and Chang J. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds. Biomaterials 25 24 (2004) 5473-5480
11. Rossi S., Azghani A.O., and Omri A. Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J Antimicrob Chemother 54 6 (2004) 1013-1018
12. Gurselt I., Yagmurlu F., Korkusuz F., and Hasirci V. In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods. J Microencapsul 19 2 (2002) 153-164
13. Turesin F., Gursel I., and Hasirci V. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J Biomater Sci Polym Ed 12 2 (2001) 195-207
14. Luzier W.D. Materials derived from biomass/biodegradable materials. Proc Natl Acad Sci USA 89 3 (1992) 839-842
15. Chen G.Q., and Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 26 33 (2005) 6565-6578
16. Taylor M., Daniels A., Andriano P., and Heller J. Six biodegradable polymers: in vivo acute toxicity of accumulated degradation production. J Appl Biomater 5 (1994) 151-157
17. van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes Jr. D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94 7 (1996) 1690-1697
18. Gogolewski S., Jovanovic M., Perren S.M., Dillon J.G., and Hughes M.K. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 27 9 (1993) 1135-1148
19. Shishatskaya E.I., Volova T.G., Puzyr A.P., Mogilnaya O.A., and Efremov S.N. Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures. J Mater Sci Mater Med 15 6 (2004) 719-728
20. Köse G.T., Korkusuz F., Korkusuz P., and Hasirci V. In vivo tissue engineering of bone using poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) and collagen scaffolds. Tissue Eng 10 7-8 (2004) 1234-1250
21. Rouxhlet L., Legras R., and Schneider Y. Interactions between a biodegradable polymer, poly(hydroxybutyrate-hydroxyvalerate), proteins and macrophages. Macromol Sympos 130 (1998) 347-366
22. Stacey K.J., Young G.R., Clark F., Sester D.P., Roberts T.L., Naik S., et al. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 170 7 (2003) 3614-3620
23. Dragoi A.M., Fu X., Ivanov S., Zhang P., Sheng L., Wu D., et al. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J 24 4 (2005) 779-789
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 1-2 (1983) 55-63
25. Green L., Wagner D., Glogowski J., Skipper P., Wishnok J., and Tannenbaum S. Analysis of nitrite, nitrate and [15N] nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
26. Slater S., Mitsky T.A., Houmiel K.L., Hao M., Reiser S.E., Taylor N.B., et al. Metabolic engineering of Arabidopsis and Brassica for poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer production. Nat Biotechnol 17 10 (1999) 1011-1016
27. Raschke W.C., Baird S., Ralph P., and Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15 (1978) 261-267
28. Cassady A.I., Stacey K.J., Nimmo K.A., Murphy K.M., von der Ahe D., Pearson D., et al. Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5′ non-coding sequences that are conserved between mouse and pig. Nucleic Acids Res 19 24 (1991) 6839-6847
29. Williams S.F., Martin D.P., Horowitz D.M., and Peoples O.P. PHA applications: addressing the price performance issue: I. Tissue engineering. Int J Biol Macromol 25 1-3 (1999) 111-121
30. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J Leukoc Biol 60 1 (1996) 8-26
31. Stacey K.J., Sweet M.J., and Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol 157 5 (1996) 2116-2122
32. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Microb Infect 6 15 (2004) 1382-1387
33. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 5396 (1998) 2085-2088
34. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 6813 (2000) 740-745
35. Ulmer A., Rietschel E., Zahringer U., and Heine H. Lipopolysaccharide: structure, bioactivity, receptors, and signal transduction. Trends Glycosci Glycotechnol 14 (2002) 53-68
36. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., and Witztum J.L. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 25 6 (2005) 1213-1219
37. Williams D. Endotoxins and medical devices: the significance of dead bacteria. Med Device Technol 14 2 (2003) 8-11
38. Sevastianov V.I., Perova N.V., Shishatskaya E.I., Kalacheva G.S., and Volova T.G. Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. J Biomater Sci Polym Ed 14 10 (2003) 1029-1042
39. Shishatskaya E.I., and Volova T.G. A comparative investigation of biodegradable polyhydroxyalkanoate films as matrices for in vitro cell cultures. J Mater Sci Mater Med 15 8 (2004) 915-923
40. Lee S.Y., Choi J., Han K., and Song J.Y. Removal of endotoxin during purification of poly(3-hydroxybutyrate) from gram-negative bacteria. Appl Environ Microbiol 65 6 (1999) 2762-2764
41. Weary M., and Pearson F. A manufacturer's guide to depyrogenation. Biopharm 29 (1988) 22-29